Cordycepin generally inhibits growth factor signal transduction in a systems pharmacology study
(2024)
Journal Article
Lawrence, S., Lin, J., Khurshid, A., Utami, W., Singhania, R., Ashraf, S., Thorn, G. J., Mangangcha, I. R., Spriggs, K., Kim, D., Barrett, D., & de Moor, C. H. (2025). Cordycepin generally inhibits growth factor signal transduction in a systems pharmacology study. FEBS Letters, 599(3), 415-435. https://doi.org/10.1002/1873-3468.15046
Cordycepin (3′ deoxyadenosine) has been widely researched as a potential cancer therapy, but many diverse mechanisms of action have been proposed. Here, we confirm that cordycepin triphosphate is likely to be the active metabolite of cordycepin and t... Read More about Cordycepin generally inhibits growth factor signal transduction in a systems pharmacology study.